ClinicalTrials.Veeva

Menu

Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study

Cairo University (CU) logo

Cairo University (CU)

Status

Enrolling

Conditions

Mycosis Fungoides

Treatments

Diagnostic Test: Skin biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT05855460
Yasmfil35

Details and patient eligibility

About

Tissue and serum samples from 20 MF patients and 20 normal healthy controls will be subjected for biochemical assessments by ELISA (Enzyme- linked immune-sorbent assay) for assessing the level of IL35.

Full description

Tissue and serum samples from 20 MF patients and 20 normal healthy controls will be subjected for biochemical assessments by ELISA (Enzyme- linked immune-sorbent assay) for assessing the level of IL35

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with mycosis fungoides. Both genders. Age group ≥ 18 years old.

Exclusion criteria

  • Patients with any other skin diseases. Patients who received treatments for mycosis fungoides in the past three months.

Subjects with history of solid or hematological malignancy as leukemia

Trial design

20 participants in 2 patient groups

Mycosis fungoides patients
Description:
Blood sample and skin biopsy for assessment of IL35 by ELISA
Treatment:
Diagnostic Test: Skin biopsy
Normal healthy controls
Description:
Blood sample and skin biopsy for assessment of IL35 levels by ELISA
Treatment:
Diagnostic Test: Skin biopsy

Trial contacts and locations

1

Loading...

Central trial contact

Sally Doss, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems